Nancy A. Johnson

Array ( [id] => 3774803 [patent_doc_number] => 05807978 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Immunogenic peptides of prostate specific antigen' [patent_app_type] => 1 [patent_app_number] => 8/472228 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13363 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807978.pdf [firstpage_image] =>[orig_patent_app_number] => 472228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781593 [patent_doc_number] => 05821124 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Hybridoma cell lines and antibodies that bind noggin' [patent_app_type] => 1 [patent_app_number] => 8/485721 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 29 [patent_no_of_words] => 21074 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821124.pdf [firstpage_image] =>[orig_patent_app_number] => 485721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3692856 [patent_doc_number] => 05595737 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Methods for using monoclonal antibodies specific for cell-surface bound LAM-1' [patent_app_type] => 1 [patent_app_number] => 8/477394 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9395 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/595/05595737.pdf [firstpage_image] =>[orig_patent_app_number] => 477394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4064725 [patent_doc_number] => 05895746 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-20 [patent_title] => 'Antibody to aminoterminal propeptide of type 1 procollagen, and assay method using it' [patent_app_type] => 1 [patent_app_number] => 8/480822 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5006 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/895/05895746.pdf [firstpage_image] =>[orig_patent_app_number] => 480822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4347984 [patent_doc_number] => 06217866 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same' [patent_app_type] => 1 [patent_app_number] => 8/487761 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 13483 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/217/06217866.pdf [firstpage_image] =>[orig_patent_app_number] => 487761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4044297 [patent_doc_number] => 05912172 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Endowing lymphocytes with antibody specificity' [patent_app_type] => 1 [patent_app_number] => 8/474819 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 6682 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912172.pdf [firstpage_image] =>[orig_patent_app_number] => 474819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3764539 [patent_doc_number] => 05852174 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Antibodies to liver derived receptors for advanced glycosylation endproducts and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/479149 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 14810 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/852/05852174.pdf [firstpage_image] =>[orig_patent_app_number] => 479149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3830513 [patent_doc_number] => 05760186 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Antibody to macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)' [patent_app_type] => 1 [patent_app_number] => 8/480342 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 15910 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/760/05760186.pdf [firstpage_image] =>[orig_patent_app_number] => 480342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3741523 [patent_doc_number] => 05801001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Method of detecting cancer' [patent_app_type] => 1 [patent_app_number] => 8/477108 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 10309 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801001.pdf [firstpage_image] =>[orig_patent_app_number] => 477108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4056518 [patent_doc_number] => 05863796 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Antibodies which specifically bind mammalian receptors for interleukin-10 (IL-10)' [patent_app_type] => 1 [patent_app_number] => 8/477166 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 32 [patent_no_of_words] => 23126 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/863/05863796.pdf [firstpage_image] =>[orig_patent_app_number] => 477166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4079992 [patent_doc_number] => 06024936 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Antibody-based method of localizing activated thrombin receptors' [patent_app_type] => 1 [patent_app_number] => 8/473489 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 31022 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/024/06024936.pdf [firstpage_image] =>[orig_patent_app_number] => 473489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3767095 [patent_doc_number] => 05849507 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Methods to diagnose thrombosis by measuring activation peptide' [patent_app_type] => 1 [patent_app_number] => 8/477362 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 29036 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849507.pdf [firstpage_image] =>[orig_patent_app_number] => 477362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3795221 [patent_doc_number] => 05780596 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Binding proteins to malignant cell type markers of the interior nuclear matrix' [patent_app_type] => 1 [patent_app_number] => 8/467781 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 12757 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780596.pdf [firstpage_image] =>[orig_patent_app_number] => 467781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4200887 [patent_doc_number] => 06013772 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Antibody preparations specifically binding to unique determinants of CEA antigens or fragments thereof and use of the antibody preparations in immunoassays' [patent_app_type] => 1 [patent_app_number] => 8/468856 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 4 [patent_no_of_words] => 22009 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013772.pdf [firstpage_image] =>[orig_patent_app_number] => 468856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4181250 [patent_doc_number] => 06037453 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Immunoglobulin variants' [patent_app_type] => 1 [patent_app_number] => 8/466151 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 26807 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037453.pdf [firstpage_image] =>[orig_patent_app_number] => 466151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3920771 [patent_doc_number] => 05876712 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated' [patent_app_type] => 1 [patent_app_number] => 8/468545 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 29 [patent_no_of_words] => 20284 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876712.pdf [firstpage_image] =>[orig_patent_app_number] => 468545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682775 [patent_doc_number] => 05695756 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Methods for treating hypertension' [patent_app_type] => 1 [patent_app_number] => 8/466795 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15740 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695756.pdf [firstpage_image] =>[orig_patent_app_number] => 466795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4236879 [patent_doc_number] => 06075122 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated' [patent_app_type] => 1 [patent_app_number] => 8/466680 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 24 [patent_no_of_words] => 23401 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/075/06075122.pdf [firstpage_image] =>[orig_patent_app_number] => 466680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4109327 [patent_doc_number] => 06022958 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'cDNAs coding for members of the carcinoembryonic antigen family' [patent_app_type] => 1 [patent_app_number] => 8/468859 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21930 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022958.pdf [firstpage_image] =>[orig_patent_app_number] => 468859 [rel_patent_id] =>[rel_patent_doc_number] =>)